128 related articles for article (PubMed ID: 34528874)
1. Risk Factors for Development of Rectal Neuroendocrine Tumors Longer Than 9 mm: Retrospective Cohort.
de Castro JSL; da Rocha ECV; do Vale VA; Mendonça P; Marques OW; Taglieri E; Koyama FSC; Cardoso Filho CAM; Nakagawa WT
Turk J Gastroenterol; 2021 Aug; 32(8):616-621. PubMed ID: 34528874
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathological characteristics and prognosis analysis of colorectal neuroendocrine neoplasms based on the data from domestic six medical centers].
Zhang Y; Peng X; Jin K; Wang W; Feng X; Zeng Y; Chen M; Yu X; Chen Y; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1235-1240. PubMed ID: 27928792
[TBL] [Abstract][Full Text] [Related]
3. [Application of dental floss traction-assisted endoscopic submucosa dissection to rectal neuroendocrine neoplasm].
Shi Q; Sun D; Zhong YS; Xu MD; Li B; Cai SL; Qi ZP; Ren Z; Zhang H; Yong YY; Yao LQ; Zhou PH
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):377-382. PubMed ID: 31054553
[No Abstract] [Full Text] [Related]
4. [Clinicopathologic characteristics and prognosis of rectal neuroendocrine neoplasms].
Liu T; Liu P; Wu T; Pan Y; Chen G; Wang P; Jiang Y; Wu Y; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1015-1019. PubMed ID: 28900992
[TBL] [Abstract][Full Text] [Related]
5. Role of endoscopic submucosal dissection in treatment of rectal gastroenteropancreatic neuroendocrine neoplasms.
Spychalski M; Koptas W; Zelga P; Dziki A
Prz Gastroenterol; 2017; 12(1):17-21. PubMed ID: 28337231
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the risk factors associated with rectal neuroendocrine tumors: a big data analytic study from a health screening center.
Pyo JH; Hong SN; Min BH; Lee JH; Chang DK; Rhee PL; Kim JJ; Choi SK; Jung SH; Son HJ; Kim YH
J Gastroenterol; 2016 Dec; 51(12):1112-1121. PubMed ID: 27025841
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Clinical Outcomes of Rectal Neuroendocrine Tumors According to the Pathologic Status After Initial Endoscopic Resection: A KASID Multicenter Study.
Moon CM; Huh KC; Jung SA; Park DI; Kim WH; Jung HM; Koh SJ; Kim JO; Jung Y; Kim KO; Kim JW; Yang DH; Shin JE; Shin SJ; Kim ES; Joo YE
Am J Gastroenterol; 2016 Sep; 111(9):1276-85. PubMed ID: 27377520
[TBL] [Abstract][Full Text] [Related]
8. Endoscopically removed rectal NETs: a nationwide cohort study.
Kuiper T; van Oijen MGH; van Velthuysen MF; van Lelyveld N; van Leerdam ME; Vleggaar FD; Klümpen HJ
Int J Colorectal Dis; 2021 Mar; 36(3):535-541. PubMed ID: 33230657
[TBL] [Abstract][Full Text] [Related]
9. Recurrence pattern and surveillance strategy for rectal neuroendocrine tumors after endoscopic resection.
Chung HG; Goh MJ; Kim ER; Hong SN; Kim TJ; Chang DK; Kim YH
J Gastroenterol Hepatol; 2021 Apr; 36(4):968-973. PubMed ID: 32864790
[TBL] [Abstract][Full Text] [Related]
10. [Subtype classification and clinicopathological characteristics of gastric neuroendocrine neoplasms: an analysis of 241 cases].
Zhang P; Zhang Y; Zhang C; Shi Y; Liu J; Liu Q; Yu L; Wang M; Zou G; Lou J; Chen J; Tan H
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1241-1246. PubMed ID: 27928793
[TBL] [Abstract][Full Text] [Related]
11. Long-term Outcome of Small, Incidentally Detected Rectal Neuroendocrine Tumors Removed by Simple Excisional Biopsy Compared With the Advanced Endoscopic Resection During Screening Colonoscopy.
Kwak MS; Chung SJ; Yang JI; Im JP; Park MJ; Lee C; Kim JS
Dis Colon Rectum; 2018 Mar; 61(3):338-346. PubMed ID: 29369898
[TBL] [Abstract][Full Text] [Related]
12. Rectal Neuroendocrine Neoplasms: Why Is There a Global Variation?
Cope J; Srirajaskanthan R
Curr Oncol Rep; 2022 Mar; 24(3):257-263. PubMed ID: 35084662
[TBL] [Abstract][Full Text] [Related]
13. Surveillance strategy for rectal neuroendocrine tumors according to recurrence risk stratification.
Kim DH; Lee JH; Cha YJ; Park SJ; Cheon JH; Kim TI; Kim H; Kim WH; Hong SP
Dig Dis Sci; 2014 Apr; 59(4):850-6. PubMed ID: 24323182
[TBL] [Abstract][Full Text] [Related]
14. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study.
Masui T; Ito T; Komoto I; Uemoto S;
BMC Cancer; 2020 Nov; 20(1):1104. PubMed ID: 33189127
[TBL] [Abstract][Full Text] [Related]
15. [Analysis on risk factors of positive vertical resection margin after endoscopic treatment of rectal neuroendocrine tumors].
Wang RG; Jiang X; Ren YT; Wang J; Guo XJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jul; 22(7):643-647. PubMed ID: 31302962
[No Abstract] [Full Text] [Related]
16. Long-term prognosis of an endoscopically treated rectal neuroendocrine tumor: 10-year experience in a single institution.
Sung HY; Kim SW; Kang WK; Kim SY; Jung CK; Cho YK; Park JM; Lee IS; Choi MG; Chung IS
Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):978-83. PubMed ID: 22647741
[TBL] [Abstract][Full Text] [Related]
17. Incidence Trends of Gastroenteropancreatic Neuroendocrine Tumors in the United States.
Lee MR; Harris C; Baeg KJ; Aronson A; Wisnivesky JP; Kim MK
Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2212-2217.e1. PubMed ID: 30580091
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors: current data on a prospectively collected, retrospectively analyzed clinical multicenter investigation.
Niederle MB; Niederle B
Oncologist; 2011; 16(5):602-13. PubMed ID: 21467149
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Metastases in Rectal Neuroendocrine Tumors: Results of a National Cohort Study.
Concors SJ; Sinnamon AJ; Folkert IW; Mahmoud NN; Fraker DL; Paulson EC; Roses RE
Dis Colon Rectum; 2018 Dec; 61(12):1372-1379. PubMed ID: 30312223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
